(1) Background: Approximately a billion people worldwide are affected by NAFLD, which
places a high clinical burden and financial cost on society. Liver biopsy is the gold standard …

Non-alcoholic fatty liver disease (NAFLD) affects an estimated one-quarter of the global
adult population and has become one of the leading causes of end-stage liver disease and …

Recent evidence shows that simple and inexpensive anthropometric measurements can be
used to identify, at an early stage, women with obesity at increased risk of developing …

Non-alcoholic fatty liver disease (NAFLD) has emerged as a leading public health challenge
and is closely associated with metabolic syndromes, such as obesity. Intestinal microbiota …

Background Non-alcoholic fatty liver disease (NAFLD) represents a large and growing
public health problem. Insulin resistance (IR) plays a crucial role in the pathogenesis of …

Non-alcoholic fatty liver disease (NAFLD) and obesity are serious public health problems.
Green tea is widely consumed in the world and different green teas could possess different …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most
common chronic liver disease in China. Our study aimed to evaluate the screening value of …

Abstract Objective This Mendelian randomization study aimed to investigate the
associations of birth weight, childhood BMI, and adulthood BMI, waist‐hip ratio, and body …

Cardiovascular disease (CVD) is the leading cause of death in patients with non-alcoholic
fatty liver disease (NAFLD). Curcumin has been shown to exert glucose-lowering and anti …

Aims: We aimed to investigate the association of visceral adiposity index (VAI) with
decreased renal function in US adults. Design and Methods: Cross-sectional data were …